Address
Email address
https://genecode.comGenecode - Developing novel
disease modifying drugsOur mission is a simple question we ask ourselves — can we slow down or stop neurodegeneration when treating chronic neurological diseases?
Name
Uno VC OÜ
Registry code
16030635
VAT number
EE102287488
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
17.08.2020 (4)
Financial year
01.01-31.12
Capital
50 000.00 €
Activity
68201 - Rental and operating of own or leased real estate
8 382 €
83 995 €
1002%
-
961 632 €
0
Submitted
No tax arrears
9%
7%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Paavo Pilv 12.02.1976 (48) | 100% - 50 000.00 EUR | Board member | Direct ownership | |
| Lembit Kaljuvee 29.12.1952 (71) | - | - | - | Founder |
| Mehis Pilv 13.01.1947 (77) | - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| MPPS Investeeringud OÜ 10634869 | 35% - 8 946.00 EUR | - | - | |
| Multilink OÜ 11040758 | 25% - 704.00 EUR | - | - |
| 2021 25.11.2022 | 2022 06.06.2023 | 2023 06.04.2024 | |
|---|---|---|---|
| Total Revenue | 0 € | 0 € | 8 382 € |
| Net profit (loss) for the period | -240 € | 481 089 € | 83 995 € |
| Profit Margin | - | - | 1002% |
| Current Assets | 26 371 € | 25 620 € | 78 934 € |
| Fixed Assets | - | 616 777 € | 1 060 611 € |
| Total Assets | 26 371 € | 642 397 € | 1 139 545 € |
| Current Liabilities | - | 1 060 € | 8 988 € |
| Non Current Liabilities | - | 11 171 € | 168 925 € |
| Total Liabilities | - | 12 231 € | 177 913 € |
| Share Capital | 40 000 € | - | - |
| Equity | 26 371 € | 630 166 € | 961 632 € |
| Employees | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | - | - | - | - |
| 2023 Q3 | - | - | - | - |
| 2023 Q2 | - | - | - | - |
| 2023 Q1 | - | - | - | - |
| 2022 Q4 | - | - | - | - |
| 2022 Q3 | - | - | - | - |
| 2022 Q2 | - | - | - | - |
| 2022 Q1 | - | - | - | - |
| 2021 Q4 | - | - | - | - |
| 2021 Q3 | - | - | - | - |
| 2021 Q2 | - | - | - | - |
| 2021 Q1 | - | - | - | - |
| 2020 Q4 | - | - | - | - |
| 2020 Q3 | - | - | - | - |
